BTB Therapeutics, Inc.
PrivateLast Round
Seed Round
Aug 12, 2026
Est. Valuation
$6.42M
Total Funding Raised
$11.96M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BTB Therapeutics, Inc. is a drug discovery company developing non-opioid analgesics and RNA-modifying compounds to treat rare genetic diseases and enhance cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BTB Therapeutics, Inc. Comparables
Compare BTB Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neumentum, Inc. | 86% | |
| Allay Therapeutics | 84% | |
| Concentric Analgesics | 83% |
BTB Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 12, 2026 | ||||
| Early Funding | Nov 1, 2025 | ||||
| Seed | Feb 5, 2025 | ||||
| Convertible Debt | Jun 24, 2024 | ||||
| Convertible Debt | Oct 27, 2023 | ||||
VC Round | Apr 4, 2023 |
Key People
Founding team and executive leadership
BTB Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kyoto University Innovation Capital | Early Funding, Convertible Debt, Seed |
| SMBC Venture Capital | Early Funding, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
Raised $9M in Seed funding.
- Nov 1, 2025
$7M raised in early funding.
BTB Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BTB Therapeutics, Inc.'s valuation, stock price, and market status.
Is BTB Therapeutics, Inc. a public or private company?
BTB Therapeutics, Inc. is a private company.
What is the current stock price of BTB Therapeutics, Inc.?
BTB Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks BTB Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BTB Therapeutics, Inc. worth (valuation)?
BTB Therapeutics, Inc.'s valuation is estimated at $6.4M based on funding round data.
Can I buy BTB Therapeutics, Inc. stock?
BTB Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BTB Therapeutics, Inc.'s last funding round?
BTB Therapeutics, Inc.'s most recent funding round was Seed Round on August 12, 2026.
Who are the main investors in BTB Therapeutics, Inc.?
Key investors in BTB Therapeutics, Inc. include Kyoto University Innovation Capital, SMBC Venture Capital.
Will BTB Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for BTB Therapeutics, Inc..
How can I track BTB Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BTB Therapeutics, Inc.'s shares on secondary markets.